New Liquid Ready-to-Use Tumor Marker Control Now Available from Randox Laboratories

22 Nov 2012

The new Randox Acusera multi-analyte Liquid Tumor Marker Control covers a total of 15 commonly tested and esoteric cancer antigens and tumor markers. The inclusion of assayed, instrument specific target values enables laboratories to effectively monitor both accuracy and precision.

The Liquid Tumor Marker Control includes AFP (Alpha-fetoprotein), Beta-2- Microglobulin, CA15-3, CA19-9, CA27-29, CA72-4, CA125, CEA (Carcinoembryonic Antigen), Cyfra 21-1, Ferritin, hCG (Human Chorionic Gonadotropin), NSE (Neuron-specific Enolase), PSA Free (Prostate Specific Antigen Free), PSA Total (Prostate Specific Antigen Total) and Thyroglobulin.

The liquid ready-to-use format is highly convenient for laboratory staff to use requiring no preparation. Furthermore the material can be easily shipped and stored at +2-8oC. Liquid stable controls not only eliminate the need for reconstitution but reduce the amount of human handling necessary. The user friendly 6 x 3ml pack size and open vial stability of 30 days at +2-8oC for all analytes listed significantly helps to minimize waste and keep running costs low.

Like all Randox immunoassay controls the serum is 100% human in origin providing a matrix similar to the patient sample but also reducing antibody cross reactivity and the possibility of control values shifting when reagent batch is changed. Three distinct levels of control are available with all analytes including PSA present at desirable levels. Clinically relevant PSA levels ensure the ratio of free to bound PSA is typical of that found in cancer patients.

As a true third party control laboratories can use the Acusera liquid tumor marker control to independently assess analytical performance. Fully assayed, instrument specific target values and ranges are provided for many common clinical chemistry and immunoassay systems.

For optimum performance and advanced analytical capabilities use in combination with Acusera 24.7 Live Online, an inter-laboratory data management programme designed to monitor analytical performance, interpret QC results and improve the effectiveness of quality control. With Acusera 24.7 users benefit from online access anytime, peer group data generated from thousands of laboratories every 24 hours, fully interactive charts and reports and automatic import of QC data direct from your LIMs or instrument via Acusera 24.7 Connect.

Liquid Tumour Marker Control

Randox Laboratories Ltd.

Our comprehensive liquid tumour marker quality control is designed to suit even the most demanding clinical laboratories covering 15 different cancer antigens and tumour markers. The inclusion of assayed, instrument specific target values enables effective monitoring of both accuracy and precision while the liquid stable format makes it highly convenient and user friendly.Features & BenefitsLiquid for ease-of-use100% human serumClinically relevant PSA levelsAssayed instrument specific target values provided for 15 parametersStable to expiry date at 2°C – 8°COpen vial stability of 30 days at 2°C – 8°CDescription - Size - Analytes - Cat NoLiquid Tumour Marker Control Level 1 - 6 x 3ml - 15 - TU5085Liquid Tumour Marker Control Level 2 - 6 x 3ml - 15 - TU5086Liquid Tumour Marker Control Level 3 - 6 x 3ml - 15 - TU5087Analytes:AFPBeta-2- MicroglobulinCA 15-3CA 19-9CA 27-29CA 72-4CA 125CEACyfra 21-1FerritinTotal β-hCGNeuron Specific Enolase (NSE)PSA (Free)PSA (Total)Thyroglobulin

(1)

Links

Tags